Flunixmaj Inj.

Description

Composition: 

Each 1 ml contains: 

Flunixin (as Flunixin meglumine) : 50 mg 

 Properties: 

Flunixmaj is a potent, non-narcotic, non-steroidal analgesic agent with anti-inflammatory and antipyretic activity.  

Flunixin is four times as potent as phynelbutazone in the reduction of lameness and swellings in horses. Plasma half-life in horse serum 1.6 hours following a single dose and 3.0 hours in bovine. 

 Indications: 

Horses: 

Alleviation of inflammation and pain associated with muscloskeletal disorders, and alleviation of visceral pain associate with colic. 

 Cattle: 

Control of pyrexia associated with bovine respiratory disease, endotoxemia and bovine mastitis, as well as control of inflammation in endotoxemia.  

Dosage and Administration: 

Horse: 

The recommended dose for musculoskeletal disorders is 1.1 mg per kg bodyweight (1 ml/ 45 kg bodyweight), once daily. 

Treatment may be given intravenous or intramuscular injection and repeated for up to 5 days. 

The recommended dose for alleviation of pain associated with equine colic is   1.1 mg per kg bodyweight (1 ml/ 45 kg bodyweight). 

Intravenous administration is recommended for prompt relief. Treatment may be repeated when signs of colic recur. 

 Cattle: 

The recommended dose for the control of pyrexia associated with bovine respiratory disease and endotoxemia is 1.1 mg/ kg to 2.2 mg/ kg bodyweight     (1 to 2 ml per 45 kg bodyweight) given by slow intravenous administration either once a day as a single dose or divided into two doses at 12 hour intervals for up to 3 days. The total daily dose should not exceed 2.2 mg/ kg bodyweight. 

Avoid rapid intravenous administration of the drug. 

The recommended dose rate for acute bovine mastitis is 2.2 mg/ kg bodyweight (2 ml/ 45 kg bodyweight) given once by intravenous administration. 

 Contraindications: 

• Intra-arterial injection should be avoided. Horses inadvertently injected intra-arterially can show adverse reactions. Signs can be ataxia, incoordination, hyperventilation, hysteria and muscle weakness. Signs are transient and disappear without antidotal medication within a few minutes. 
• Do not use in animals showing hypersensitivity to flunixin meglumine. 
• Use judiciously when renal impairment or gastric ulceration are suspected. 
• Do not administer other non-steroidal anti-inflammatory drugs concurrently or within 24 hours. 

 Warnings: 

• Do not exceed the recommended dose or duration of treatment. 
• Do not use in animals less than 6 weeks of age or in aged animals. 

 Withdrawal Period: 

• Cattle must not be slaughtered for human consumption within 4 days of the last treatment. 
• Milk that has been taken during treatment and for 36 hours after the last treatment must not be used for food. 
• Not for use in dry dairy cows. 
• Do not use in calves to be processed for veal. 

• Not for use in horses intended for food. 

 Storage: 

Store at temperature below 30oC